Amendment to the Universal Waste Rule: Addition of Pharmaceuticals (Proposed Rule)

ICR 200812-2050-003

OMB: 2050-0200

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2008-11-24
IC Document Collections
IC ID
Document
Title
Status
187392
New
ICR Details
2050-0200 200812-2050-003
Historical Inactive
EPA/OLEM 2324.01
Amendment to the Universal Waste Rule: Addition of Pharmaceuticals (Proposed Rule)
New collection (Request for a new OMB Control Number)   No
Regular
Comment filed on proposed rule 05/01/2009
Retrieve Notice of Action (NOA) 12/02/2008
This OMB action is not an approval to conduct or sponsor an information collection under the Paperwork Reduction Act of 1995. This action has no effect on any current approvals. If OMB has assigned this ICR a new OMB Control Number, the OMB Control Number will not appear in the active inventory. For future submissions of this information collection, reference the OMB Control Number provided. In accordance with 5 CFR 1320, OMB is withholding approval for this request at this time. Prior to the publication of the final rule, the agency should provide a summary of all comments related to the information collection and anychanges made in response to these comments.
  Inventory as of this Action Requested Previously Approved
36 Months From Approved
0 0 0
0 0 0
0 0 0

EPA is proposing to add hazardous pharmaceutical wastes to the existing Universal Waste Rule (UWR) at 40 CFR Part 273. This proposed rule would facilitate better management of pharmaceutical wastes by streamlining the generator requirements and encouraging generators of hazardous pharmaceutical wastes to manage them under the provisions of the UWR, which ensures that these hazardous pharmaceutical wastes are properly disposed of and treated as hazardous wastes. In addition, this proposed rule would facilitate the implementation of pharmaceutical take-back programs, and thus would redirect hazardous and non-hazardous pharmaceutical wastes from municipal solid waste landfills and sewer systems to hazardous waste landfills and incinerators.

US Code: 42 USC 912(a), 6921, 6922, 6924, 6926 Name of Law: Hazardous and Solid Waste Amendments of 1984 (HSWA)
  
None

2050-AG39 Proposed rulemaking 73 FR 73520 12/02/2008

No

1
IC Title Form No. Form Name
Addition of Pharmaceuticals - Private Sector

Yes
Changing Regulations
No
EPA is proposing to add hazardous pharmaceutical wastes to the Universal Waste Rule (UWR). This is expected to improve management of hazardous and non-hazardous pharmaceutical wastes, as well as decreased regulatory burden for many hazardous pharmaceutical waste generators. The increase in burden would result from the need for universal pharmaceutical waste handlers to read the rule that adds hazardous pharmaceutical wastes to the existing UWR. In addition, the large quantity handlers would also be required to maintain records of all universal pharmaceutical waste shipments. The total increase in new annual paperwork requirements in the proposed rule is approximately 960 hours. However, in addition to the new paperwork requirements for respondents, the proposed rule would result in annual respondent burden savings under the existing paperwork requirements (associated with four existing EPA ICRs) of approximately 1,900 hours. Taking both the new proposed and existing RCRA requirements into account, the proposed rule would result in a net reduction in annual paperwork burden of approximately 935 hours.

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected
Narendra Chaudhari 703 308-0454 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/02/2008


© 2024 OMB.report | Privacy Policy